Search Results

You are looking at 61 - 70 of 130 items for :

  • "prognosis" x
Clear All
Open access

R C S van Adrichem, L J Hofland, R A Feelders, M C De Martino, P M van Koetsveld, C H J van Eijck, R R de Krijger, D M Sprij-Mooij, J A M J L Janssen and W W de Herder

. Cancer 2008 15 256 – 265 . ( doi:10.1002/cncr.23549 ). 14 Strosberg J Nasir A Coppola D Wick M Kvols L . Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors . Human Pathology 2009 40

Open access

Bjørn O Åsvold, Valdemar Grill, Ketil Thorstensen and Marit R Bjørgaas

Juul S Jørgensen JO Astrup J Bjerre P Feldt-Rasmussen U Hagen C Jørgensen J Kosteljanetz M Kristensen L Laurberg P Schmidt K Weeke J . Incidence and late prognosis of Cushing's syndrome: a population-based study . Journal of

Open access

Merete Gedde-Dahl, Espen Thiis-Evensen, Andreas Myklebust Tjølsen, Kjerstin Skrede Mordal, Morten Vatn and Deidi S Bergestuen

biological variation and is therefore considered more useful in diagnosis and follow-up of patients with NETs. In addition to its value in diagnosis and follow-up of patients with NETs (2, 9, 10) , U5-HIAA is also associated with prognosis (11, 12

Open access

Angelo Maria Patti, Kalliopi Pafili, Nikolaos Papanas and Manfredi Rizzo

.2174/1389201015666140330193653 24720595 11 Dukler D Porath A Bashiri A Erez O Mazor M. Remote prognosis of primiparous women with preeclampsia . European Journal of Obstetrics, Gynecology and Reproductive Biology 2001 96 69 – 74 . (

Open access

Ermina Bach, Niels Møller, Jens Otto L Jørgensen, Mads Buhl and Holger Jon Møller

immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis . Clinical and Experimental Immunology 2008 151 423 – 431 . (

Open access

Madalena von Hafe, João Sergio Neves, Catarina Vale, Marta Borges-Canha and Adelino Leite-Moreira

ventricular asynchrony is also present in hypothyroidism, which affects diastolic and systolic functions, exercise capacity, and quality of life, rendering potential heart failure patients more symptomatic and worsening their prognosis ( 58 ). CHD that

Open access

C E Higham, A Olsson-Brown, P Carroll, T Cooksley, J Larkin, P Lorigan, D Morganstein, P J Trainer and the Society for Endocrinology Clinical Committee

Introduction Immunotherapy treatment with checkpoint inhibitors (CPI) such as ipilimumab (CTLA-4 inhibitor), nivolumab and pembrolizumab (PD-1 inhibitors) significantly improves prognosis in a number of cancers ( 1 , 2 , 3 ). Combination

Open access

Danuta Gąsior-Perczak, Iwona Pałyga, Monika Szymonek, Artur Kowalik, Agnieszka Walczyk, Janusz Kopczyński, Katarzyna Lizis-Kolus, Anna Słuszniak, Janusz Słuszniak, Tomasz Łopatyński, Ryszard Mężyk, Stanisław Góźdź and Aldona Kowalska

-stage disease and a low risk of unfavorable clinical outcomes showed a good prognosis irrespective of the extent of TT or L surgery. The risk of disease recurrence in the present study was low (0.7%), although recurrence was possible regardless of the response

Open access

Deborah Cosentini, Salvatore Grisanti, Alberto Dalla Volta, Marta Laganà, Chiara Fiorentini, Paola Perotti, Sandra Sigala and Alfredo Berruti

Editorial Adrenocortical carcinoma (ACC) is a rare endocrine neoplasia characterized by an overall dismal prognosis and its clinical manifestations are the consequence of either steroid excess or tumor mass progression ( 1 ). Surgery is the

Open access

Prachi Bansal, Anurag Lila, Manjunath Goroshi, Swati Jadhav, Nilesh Lomte, Kunal Thakkar, Atul Goel, Abhidha Shah, Shilpa Sankhe, Naina Goel, Neelam Jaguste, Tushar Bandgar and Nalini Shah

, declining adrenal autonomy or cortisol cyclicity and need to be studied in future ( 17 ). Predictors of remission Studying factors affecting remission is important to predict prognosis of patients undergoing TSS. Table 3 lists studies that have